The slip
PARKINSON RECEIPTno. 3379
19 Oct 2026, 18:39 UTCastrocytes, braak
predictionTTPA in astrocytes tracks Braak Lewy-body stage
registeredd2258b6a0dc04813
discovery-0.19 p=0.631 n=9
replication+0.11 p=0.787 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.19, p 0.631)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTa1638d76c144f1406d4c5f22…
follows a2d307b59040…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3379: TTPA in astrocytes, braak
- power
- full sample +0.16 (p 0.532, n 18), 95% CI -0.33 to +0.58. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.20 (p 0.434, n 18). does not hold up.
- composition
- astrocytes share of nuclei vs axis -0.21 (p 0.413); controlling for it: +0.20 (p 0.434, n 18). could be the mix.
- skeptic
- leave-one-out range +0.05 to +0.27, sign flips 0; without severely affected donors +0.16 (p 0.532, n 18). fragile.
- cell type
- strongest in dopamine neurons: +0.66 (p 0.0026, n 18) vs +0.16 in astrocytes. proposing dopamine neurons.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TTPA in astrocytes.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TTPA · dopamine neurons · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.43 p 0.131 (needs p < 5.5e-4)